Is this SDS the latest revision?

This Safety Data Sheet was issued by GlaxoSmithKline on 21 May 2018 under GHS/CLP. ISDSS syncs its database regularly to keep documents current.

Do I need to register to download this SDS?

Yes, a free ISDSS account is required to download the PDF. Registration takes under two minutes and gives you access to over 1.5 million Safety Data Sheets. Once registered, you can also save documents to your personal library for quick access.

Who is responsible for providing an SDS?

The manufacturer, importer or supplier that places the substance on the market is responsible for providing a current Safety Data Sheet to downstream users, free of charge.

Can I use this SDS as my COSHH risk assessment?

No. An SDS provides the hazard information you need, but a COSHH assessment must consider how the substance is actually used in your workplace. The matching Chemical Risk Assessment (CRA) on this page is a starting point you should adapt to your own tasks and controls.

Safety Data SheetChemical Risk Assessment

Epzicom Tablets

by GlaxoSmithKline

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Epzicom Tablets is supplied by GlaxoSmithKline under product code EPZICOM 600 MG/300 MG TABLETS, KIVEXA 600 MG/300 MG TABLETS, ABC/3TC COMBINATION TABLETS. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 21 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.

Language: English
Regulation: GHS/CLP
Revision Date: 21 May 2018
Signal Word: DANGER
Product Code: EPZICOM 600 MG/300 MG TABLETS, KIVEXA 600 MG/300 MG TABLETS, ABC/3TC COMBINATION TABLETS
CAS Number: 188062-50-2,134678-17-4,9004-34-6,557-04-0,13463-67-7

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet

Signal Word: DANGER

GHS07Harmful / irritant

GHS05Corrosive

GHS08Health hazard

Hazard Statements (H-phrases)

+548+EEC: See full Safety Data Sheet for the hazard statement wording.
H317: May cause an allergic skin reaction.
H318: Causes serious eye damage.
H341: Suspected of causing genetic defects.
H350: May cause cancer.
H351: Suspected of causing cancer.
H361: Suspected of damaging fertility or the unborn child.
H372: Causes damage to organs through prolonged or repeated exposure.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.

Common QuestionsAbout this Safety Data Sheet

Chemical Risk Assessment SummaryFrom the Chemical Risk Assessment

Assessment Summary

This Chemical Risk Assessment is derived from the Safety Data Sheet for Epzicom Tablets issued by Glaxosmithkline on 21 May 2018 It presents the substance's hazards organised by risk level, with the relevant regulatory statements and recommended controls for each. These hazards are rated across two levels: High and Low Risk, based on the hazard classifications in the SDS.

Hazard PreviewA snapshot of substance hazards and controls

Rating Before Controls

HIGH RISK

H350: May cause cancer

P201 Obtain special instructions before use

P202 Do not handle until all safety precautions have been read and un-derstood.

P281 Use personal protective equipment as required.

P501 Dispose of contents/container to correct disposal area.

P405 Store locked up

P308 + P313 IF exposed or concerned: Get medical advice/attention.

Rating Before Controls

HIGH RISK

H361: Suspected of damaging fertility or the unborn child

P201 Obtain special instructions before use.

P202 Do not handle until all safety precautions have been read and un- derstood.

P281 Use personal protective equipment as required.

P405 Store locked up

P501 Dispose of contents/container to correct disposal area.

P308 + P313 IF exposed or concerned: Get medical advice/attention.

Rating Before Controls

HIGH RISK

H318: Causes serious eye damage

P280: Wear protective gloves/protective clothing/eye protection/face protection.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

P310 Immediately call a POISON CENTER or doctor/physician

Note: This is a preview of the substance's hazards. A substance commonly carries more hazards. Download the full Chemical Risk Assessment for more information.

Recommended Control MeasuresKey PPE and handling controls

Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.

Common QuestionsAbout this Risk Assessment

Free with ISDSS

Manage Your SDS Library

Build a personal library of every SDS your workplace uses. Search, download and access documents any time you need them.

Epzicom Tablets

Need help with Safety Data Sheets? You've come to the right place!

Follow Us